Due to its widely recognized role in immunomodulation, the Gas6/TAM axis has also been investigated in the context of COVID-19, especially considering that one of the distinctive hallmarks of the severe disease is represented by an hyperinflammatory response, accountable for both disease severity and long-term sequelae [3,14,131,139,140,141,142]. This evidence concerns the gene GAS6 and COVID-19.